Could a common mood stabilizer slow Parkinson's? new study investigates
NCT ID NCT06592014
First seen Nov 19, 2025 · Last updated May 15, 2026 · Updated 21 times
Summary
This study is testing whether low-dose lithium can slow the progression of Parkinson's disease. It involves 35 people who have already completed a previous lithium trial. Over 24 weeks, researchers will use brain scans and blood tests to look for changes in disease markers. The goal is to see if lithium can modify the course of the disease, not just ease symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UBMD Neurology
Williamsville, New York, 14221, United States
Conditions
Explore the condition pages connected to this study.